Literature DB >> 25171451

Congenital amegakaryocytic thrombocytopenia: a case report of pediatric twins undergoing matched unrelated bone marrow transplantation.

Amulya A N Rao1, Julia A Gourde, Preethi Marri, Paul J Galardy, Shakila P Khan, Vilmarie Rodriguez.   

Abstract

Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare inherited disorder that presents with thrombocytopenia in infancy and evolves into bone marrow failure over time. Allogeneic hematopoietic stem cell transplant remains the only curative treatment option. We report our experience with identical twin sisters diagnosed with CAMT and treated successfully with matched unrelated donor bone marrow transplants. Before the transplant, 1 twin developed pancytopenia, whereas the other had a relatively benign clinical course. Choice of conditioning regimens was based on their pretransplant bone marrow cellularity and presence or absence of panyhypoplasia. Both twins tolerated the procedure well with no significant complications.

Entities:  

Mesh:

Year:  2015        PMID: 25171451     DOI: 10.1097/MPH.0000000000000247

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  2 in total

1.  Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD.

Authors:  N N Shah; M Parta; K Baird; H Rafei; K Cole; S M Holland; D D Hickstein
Journal:  Bone Marrow Transplant       Date:  2017-08-21       Impact factor: 5.483

2.  Outcomes in Hematopoietic Stem Cell Transplantation for Congenital Amegakaryocytic Thrombocytopenia.

Authors:  Maria Cancio; Kyle Hebert; Soyoung Kim; Mahmoud Aljurf; Timothy Olson; Eric Anderson; Lauri Burroughs; Anant Vatsayan; Kasiani Myers; Hasan Hashem; Rabi Hanna; Biljana Horn; Tim Prestidge; Jaap-Jan Boelens; Farid Boulad; Mary Eapen
Journal:  Transplant Cell Ther       Date:  2021-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.